JP2022527054A5 - - Google Patents

Info

Publication number
JP2022527054A5
JP2022527054A5 JP2021556771A JP2021556771A JP2022527054A5 JP 2022527054 A5 JP2022527054 A5 JP 2022527054A5 JP 2021556771 A JP2021556771 A JP 2021556771A JP 2021556771 A JP2021556771 A JP 2021556771A JP 2022527054 A5 JP2022527054 A5 JP 2022527054A5
Authority
JP
Japan
Prior art keywords
dry powder
pharmaceutical composition
approximately
composition according
microcrystalline particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021556771A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022527054A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/023977 external-priority patent/WO2020198051A1/en
Publication of JP2022527054A publication Critical patent/JP2022527054A/ja
Publication of JP2022527054A5 publication Critical patent/JP2022527054A5/ja
Priority to JP2025002002A priority Critical patent/JP2025061049A/ja
Pending legal-status Critical Current

Links

JP2021556771A 2019-03-22 2020-03-20 吸入可能な乾燥粉末 Pending JP2022527054A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025002002A JP2025061049A (ja) 2019-03-22 2025-01-06 吸入可能な乾燥粉末

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962822303P 2019-03-22 2019-03-22
US62/822,303 2019-03-22
PCT/US2020/023977 WO2020198051A1 (en) 2019-03-22 2020-03-20 Inhalable dry powders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025002002A Division JP2025061049A (ja) 2019-03-22 2025-01-06 吸入可能な乾燥粉末

Publications (2)

Publication Number Publication Date
JP2022527054A JP2022527054A (ja) 2022-05-30
JP2022527054A5 true JP2022527054A5 (https=) 2024-06-04

Family

ID=72608595

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021556771A Pending JP2022527054A (ja) 2019-03-22 2020-03-20 吸入可能な乾燥粉末
JP2025002002A Pending JP2025061049A (ja) 2019-03-22 2025-01-06 吸入可能な乾燥粉末

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025002002A Pending JP2025061049A (ja) 2019-03-22 2025-01-06 吸入可能な乾燥粉末

Country Status (6)

Country Link
US (1) US20220241271A1 (https=)
EP (1) EP3941438A4 (https=)
JP (2) JP2022527054A (https=)
CA (1) CA3133804A1 (https=)
MX (2) MX2021011491A (https=)
WO (1) WO2020198051A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3171220A1 (en) * 2020-03-19 2021-09-23 Glenn MATTES Dried particle inhalation for delivery of cannabis
US20240050450A1 (en) * 2020-10-16 2024-02-15 Michael Ogburn Inhalable Cannabinoid Formulations
KR20240093906A (ko) * 2021-10-27 2024-06-24 맨카인드 코포레이션 폐고혈압을 치료하기 위한 방법 및 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60017152D1 (de) * 1999-08-25 2005-02-03 Advanced Inhalation Res Inc Grosse poröse partikel erhältlich durch sprühtrocknung und geeignet zur pulmonalen anwendung
US20010036481A1 (en) * 1999-08-25 2001-11-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US20060039866A1 (en) * 2004-08-20 2006-02-23 Cypress Bioscience, Inc. Method for treating sleep-related breathing disorders
KR101644250B1 (ko) * 2004-08-23 2016-07-29 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
IN2015DN00888A (https=) * 2006-02-22 2015-07-10 Mannkind Corp
ES2929343T3 (es) * 2008-06-13 2022-11-28 Mannkind Corp Inhalador de polvo seco accionado por aspiración para la administración de fármacos
PT3470057T (pt) * 2010-09-29 2021-12-03 Pulmatrix Operating Co Inc Pós secos catiónicos compreendendo sais de magnésio
PE20181295A1 (es) * 2015-09-01 2018-08-07 First Wave Bio Inc Metodos y composiciones para tratar afecciones asociadas a una respuesta inflamatoria anomala
CA3012679C (en) * 2016-01-29 2023-12-12 Mannkind Corporation Dry powder inhaler

Similar Documents

Publication Publication Date Title
CN103052380B (zh) 包含治疗活性物质的湿润颗粒
AU2025204271A1 (en) Microcrystalline diketopiperazine compositions and methods
JP4378057B2 (ja) 流動抵抗調節されたエアロゾル化活性薬剤送達
CN110996912A (zh) 用于鼻内递送的干粉组合物
JP7048642B2 (ja) 肺、鼻、舌下および／または咽頭への送達に適した、少なくとも１つの生物活性化合物をロードした多孔質シリカ粒子の製造方法
JP2023078269A5 (https=)
JP2001517691A5 (https=)
JPH08504438A (ja) 医薬活性化合物を投与するための系
JP2022527054A5 (https=)
BR112013029803B1 (pt) Composições de vancomicina em pó seco
JP2008518007A5 (https=)
RU2007119721A (ru) Частицы для лечения легочной инфекции
AU2021261049A1 (en) Products of manufacture and methods for treating, ameliorating or preventing microbial infections
JP2025061049A (ja) 吸入可能な乾燥粉末
AU2025200588A1 (en) Surfactant Formulations for Inhalation
JP2021510723A5 (https=)
KR20200115560A (ko) 흡입형 치료제의 고용량 전달
WO2012051050A1 (en) Method for treating cystic fibrosis with inhaled denufosol
CA3085943A1 (en) Surfactant formulations for inhalation
JP2023524064A (ja) ウイルス感染を治療又は予防するためのクロファジミン組成物及び方法
Dhahir et al. Dry powder inhalers: main characteristics, classifications and novel drug delivery systems review
JP7679093B2 (ja) 呼吸器系傷害改善用医薬組成物
Rawat et al. Nanotechnology-Based Drug Delivery Systems for the Treatment of Pulmonary Diseases
Manzanedo et al. Formulation characterization of a novel levofloxacin pulmonary dry powder drug delivery technology
Kumar et al. Nanostructure-Based Pulmonary Drug Delivery Systems for Respiratory Infections